After Treatment with Methylene Blue is Effective against Delayed Encephalopathy after Acute Carbon Monoxide Poisoning

Ningjun Zhao, Pengchong Liang, Xiaoying Zhuo, Chenglei Su, Xuemei Zong, Bingnan Guo, Dong Han, Xianliang Yan, Shuqun Hu, Quanguang Zhang, Xu Tie

Research output: Contribution to journalArticle

  • 2 Citations

Abstract

Delayed encephalopathy after acute carbon monoxide (CO) poisoning (DEACMP) is the most severe and clinically intractable complication that occurs following acute CO poisoning. Unfortunately, the mechanism of DEACMP is still vague. Growing evidence indicates that delayed cerebral damage after CO poisoning is related to oxidative stress, abnormal neuro-inflammation, apoptosis and immune-mediated injury. Our recent report indicated that methylene blue (MB) may be a promising therapeutic agent in the prevention of neuronal cell death and cognitive deficits after transient global cerebral ischaemia (GCI). In this study, we aimed to investigate the potential of MB therapy to ameliorate the signs and symptoms of DEACMP. Rats were exposed to 1000 ppm CO for 40 min. in the first step; CO was then increased to 3000 ppm, which was maintained for another 20 min. The rats were implanted with 7-day release Alzet osmotic mini-pumps subcutaneously under the back skin, which provided MB at a dose of 0.5 mg/kg/day 1 hr after CO exposure. The results showed that MB significantly suppressed oxidative damage and expression of pro-inflammatory factors, including tumour necrosis factor-α and interleukin (IL)-1β. MB treatment also suitably modulated mitochondrial fission and fusion, which is helpful in the preservation of mitochondrial function. Furthermore, MB dramatically attenuated apoptosis and neuronal death. Lastly, behavioural studies revealed that MB treatment preserved spatial learning and memory in the Barnes maze test. Our findings indicated that MB may have protective effects against DEACMP.

LanguageEnglish (US)
Pages470-480
Number of pages11
JournalBasic and Clinical Pharmacology and Toxicology
Volume122
Issue number5
DOIs
StatePublished - May 1 2018

Fingerprint

Carbon Monoxide Poisoning
Methylene Blue
Brain Diseases
Carbon Monoxide
Rats
Mitochondrial Dynamics
Apoptosis
Oxidative stress
Transient Ischemic Attack
Cell death
Interleukin-1beta
Signs and Symptoms
Skin
Oxidative Stress
Cell Death
Fusion reactions
Tumor Necrosis Factor-alpha
Pumps
Inflammation
Data storage equipment

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology

Cite this

After Treatment with Methylene Blue is Effective against Delayed Encephalopathy after Acute Carbon Monoxide Poisoning. / Zhao, Ningjun; Liang, Pengchong; Zhuo, Xiaoying; Su, Chenglei; Zong, Xuemei; Guo, Bingnan; Han, Dong; Yan, Xianliang; Hu, Shuqun; Zhang, Quanguang; Tie, Xu.

In: Basic and Clinical Pharmacology and Toxicology, Vol. 122, No. 5, 01.05.2018, p. 470-480.

Research output: Contribution to journalArticle

Zhao, Ningjun ; Liang, Pengchong ; Zhuo, Xiaoying ; Su, Chenglei ; Zong, Xuemei ; Guo, Bingnan ; Han, Dong ; Yan, Xianliang ; Hu, Shuqun ; Zhang, Quanguang ; Tie, Xu. / After Treatment with Methylene Blue is Effective against Delayed Encephalopathy after Acute Carbon Monoxide Poisoning. In: Basic and Clinical Pharmacology and Toxicology. 2018 ; Vol. 122, No. 5. pp. 470-480.
@article{8307c5ff3b1d46898fdc7eb686d78d54,
title = "After Treatment with Methylene Blue is Effective against Delayed Encephalopathy after Acute Carbon Monoxide Poisoning",
abstract = "Delayed encephalopathy after acute carbon monoxide (CO) poisoning (DEACMP) is the most severe and clinically intractable complication that occurs following acute CO poisoning. Unfortunately, the mechanism of DEACMP is still vague. Growing evidence indicates that delayed cerebral damage after CO poisoning is related to oxidative stress, abnormal neuro-inflammation, apoptosis and immune-mediated injury. Our recent report indicated that methylene blue (MB) may be a promising therapeutic agent in the prevention of neuronal cell death and cognitive deficits after transient global cerebral ischaemia (GCI). In this study, we aimed to investigate the potential of MB therapy to ameliorate the signs and symptoms of DEACMP. Rats were exposed to 1000 ppm CO for 40 min. in the first step; CO was then increased to 3000 ppm, which was maintained for another 20 min. The rats were implanted with 7-day release Alzet osmotic mini-pumps subcutaneously under the back skin, which provided MB at a dose of 0.5 mg/kg/day 1 hr after CO exposure. The results showed that MB significantly suppressed oxidative damage and expression of pro-inflammatory factors, including tumour necrosis factor-α and interleukin (IL)-1β. MB treatment also suitably modulated mitochondrial fission and fusion, which is helpful in the preservation of mitochondrial function. Furthermore, MB dramatically attenuated apoptosis and neuronal death. Lastly, behavioural studies revealed that MB treatment preserved spatial learning and memory in the Barnes maze test. Our findings indicated that MB may have protective effects against DEACMP.",
author = "Ningjun Zhao and Pengchong Liang and Xiaoying Zhuo and Chenglei Su and Xuemei Zong and Bingnan Guo and Dong Han and Xianliang Yan and Shuqun Hu and Quanguang Zhang and Xu Tie",
year = "2018",
month = "5",
day = "1",
doi = "10.1111/bcpt.12940",
language = "English (US)",
volume = "122",
pages = "470--480",
journal = "Basic and Clinical Pharmacology and Toxicology",
issn = "1742-7835",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - After Treatment with Methylene Blue is Effective against Delayed Encephalopathy after Acute Carbon Monoxide Poisoning

AU - Zhao, Ningjun

AU - Liang, Pengchong

AU - Zhuo, Xiaoying

AU - Su, Chenglei

AU - Zong, Xuemei

AU - Guo, Bingnan

AU - Han, Dong

AU - Yan, Xianliang

AU - Hu, Shuqun

AU - Zhang, Quanguang

AU - Tie, Xu

PY - 2018/5/1

Y1 - 2018/5/1

N2 - Delayed encephalopathy after acute carbon monoxide (CO) poisoning (DEACMP) is the most severe and clinically intractable complication that occurs following acute CO poisoning. Unfortunately, the mechanism of DEACMP is still vague. Growing evidence indicates that delayed cerebral damage after CO poisoning is related to oxidative stress, abnormal neuro-inflammation, apoptosis and immune-mediated injury. Our recent report indicated that methylene blue (MB) may be a promising therapeutic agent in the prevention of neuronal cell death and cognitive deficits after transient global cerebral ischaemia (GCI). In this study, we aimed to investigate the potential of MB therapy to ameliorate the signs and symptoms of DEACMP. Rats were exposed to 1000 ppm CO for 40 min. in the first step; CO was then increased to 3000 ppm, which was maintained for another 20 min. The rats were implanted with 7-day release Alzet osmotic mini-pumps subcutaneously under the back skin, which provided MB at a dose of 0.5 mg/kg/day 1 hr after CO exposure. The results showed that MB significantly suppressed oxidative damage and expression of pro-inflammatory factors, including tumour necrosis factor-α and interleukin (IL)-1β. MB treatment also suitably modulated mitochondrial fission and fusion, which is helpful in the preservation of mitochondrial function. Furthermore, MB dramatically attenuated apoptosis and neuronal death. Lastly, behavioural studies revealed that MB treatment preserved spatial learning and memory in the Barnes maze test. Our findings indicated that MB may have protective effects against DEACMP.

AB - Delayed encephalopathy after acute carbon monoxide (CO) poisoning (DEACMP) is the most severe and clinically intractable complication that occurs following acute CO poisoning. Unfortunately, the mechanism of DEACMP is still vague. Growing evidence indicates that delayed cerebral damage after CO poisoning is related to oxidative stress, abnormal neuro-inflammation, apoptosis and immune-mediated injury. Our recent report indicated that methylene blue (MB) may be a promising therapeutic agent in the prevention of neuronal cell death and cognitive deficits after transient global cerebral ischaemia (GCI). In this study, we aimed to investigate the potential of MB therapy to ameliorate the signs and symptoms of DEACMP. Rats were exposed to 1000 ppm CO for 40 min. in the first step; CO was then increased to 3000 ppm, which was maintained for another 20 min. The rats were implanted with 7-day release Alzet osmotic mini-pumps subcutaneously under the back skin, which provided MB at a dose of 0.5 mg/kg/day 1 hr after CO exposure. The results showed that MB significantly suppressed oxidative damage and expression of pro-inflammatory factors, including tumour necrosis factor-α and interleukin (IL)-1β. MB treatment also suitably modulated mitochondrial fission and fusion, which is helpful in the preservation of mitochondrial function. Furthermore, MB dramatically attenuated apoptosis and neuronal death. Lastly, behavioural studies revealed that MB treatment preserved spatial learning and memory in the Barnes maze test. Our findings indicated that MB may have protective effects against DEACMP.

UR - http://www.scopus.com/inward/record.url?scp=85038966723&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85038966723&partnerID=8YFLogxK

U2 - 10.1111/bcpt.12940

DO - 10.1111/bcpt.12940

M3 - Article

VL - 122

SP - 470

EP - 480

JO - Basic and Clinical Pharmacology and Toxicology

T2 - Basic and Clinical Pharmacology and Toxicology

JF - Basic and Clinical Pharmacology and Toxicology

SN - 1742-7835

IS - 5

ER -